Genetic Technologies LimitedASX: GTG

GeneType identifies 79.5% at risk of serious disease

· Issued by Genetic Technologies Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Genetic Technologies Limited announces that its geneType test identifies a significant percentage of individuals at risk for serious diseases, highlighting its effectiveness in preventive healthcare. The results indicate that a large portion of those tested showed elevated risks for various conditions, emphasizing the importance of early detection and intervention. The announcement underscores the advantages of geneType's non-invasive testing approach and its potential to improve health outcomes through personalized care.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Genetic Technologies Limited on 6ix

Earlier from Genetic Technologies

Later from Genetic Technologies

All Genetic Technologies news releases